These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12433795)

  • 1. Deacylation of N-arylformamides and N-arylacetamides by formamidase in rat liver.
    Ueda O; Kitamura S; Ohta S
    Drug Metab Dispos; 2002 Dec; 30(12):1297-9. PubMed ID: 12433795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on metabolic formation of N-arylformamides and N-arylacetamides from carcinogenic arylamines in mammalian species.
    Tatsumi K; Kitamura S; Amano H; Ueda K
    Cancer Res; 1989 Apr; 49(8):2059-64. PubMed ID: 2702648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N- and O-deacetylation of N-acetoxy-N-arylacetamides by mammalian hepatic microsomes.
    Yamada H; Lee MS; Wang CY
    Carcinogenesis; 1988 Nov; 9(11):1995-2002. PubMed ID: 3180338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymic deacetylation of carcinogenic arylacetamides by tissue microsomes of the dog and other species.
    Lower GM; Bryan GT
    J Toxicol Environ Health; 1976 Jan; 1(3):421-32. PubMed ID: 1550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New formamidase having substrate specificity for o-formylaminoacetophenone in pig liver.
    Shinohara R; Ishiguro I
    Biochim Biophys Acta; 1977 Aug; 483(2):409-15. PubMed ID: 70225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 2-nitrofluorene, an environmental pollutant, by liver preparations of sea bream, Pagrus major.
    Ueda O; Kitamura S; Ohta S
    Xenobiotica; 2002 Aug; 32(8):667-82. PubMed ID: 12296988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
    Flammang TJ; Kadlubar FF
    Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deacylation of carcinogenic 5-nitrofuran derivatives by mammalian tissues.
    Wang CY; Bryan GT
    Chem Biol Interact; 1974 Dec; 9(6):423-8. PubMed ID: 4434567
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster.
    Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ
    Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acylation and deacylation reactions catalyzed by kynurenine formamidase.
    Santti RS; Hopsu-Havu VK
    Acta Chem Scand; 1970; 24(3):791-6. PubMed ID: 4194551
    [No Abstract]   [Full Text] [Related]  

  • 11. The essential role of microsomal deacetylase activity in the metabolic activation, DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation and initiation of liver tumors by N-hydroxy-2-acetylaminofluorene in the livers of infant male B6C3F1 mice.
    Lai CC; Miller EC; Miller JA; Liem A
    Carcinogenesis; 1988 Jul; 9(7):1295-302. PubMed ID: 3383346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic metabolism of N-hydroxy-N-methyl-4-aminoazobenzene and other N-hydroxy arylamines to reactive sulfuric acid esters.
    Kadlubar FF; Miller JA; Miller EC
    Cancer Res; 1976 Jul; 36(7 PT 1):2350-9. PubMed ID: 819129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique tertiary amine N-oxide reduction system composed of quinone reductase and heme in rat liver preparations.
    Kitamura S; Sugihara K; Tatsumi K
    Drug Metab Dispos; 1999 Jan; 27(1):92-7. PubMed ID: 9884315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal development and sex-related difference of metyrapone reductase activities in liver microsomes and cytosol of the rat.
    Imamura Y; Murata H; Otagiri M
    Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):101-10. PubMed ID: 8272569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deacetylation of N-arylacetamides in vitro.
    Gorrod JW
    Biochem J; 1971 Jun; 123(2):10P-11P. PubMed ID: 5127327
    [No Abstract]   [Full Text] [Related]  

  • 17. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
    Eberhart DC; Gemzik B; Halvorson MR; Parkinson A
    Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-hydroxy-N-arylacetamides. II: Molecular aspects of ferrihaemoglobin formation by N-hydroxy-N-arylacetamides and arylhydroxylamines in the rat.
    Lenk W; Sterzl H
    Xenobiotica; 1986 Aug; 16(8):703-16. PubMed ID: 3765653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of arsenate to arsenite in hepatic cytosol.
    Németi B; Gregus Z
    Toxicol Sci; 2002 Nov; 70(1):4-12. PubMed ID: 12388829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine nucleoside phosphorylase as a cytosolic arsenate reductase.
    Gregus Z; Németi B
    Toxicol Sci; 2002 Nov; 70(1):13-9. PubMed ID: 12388830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.